Industry News
Pharmaceutical Industry News
Fewer Pregnant Women Received Acetaminophen in E.R.s After White House Warnings
A new analysis of prescription data found that emergency room orders for acetaminophen for pregnant women fell for weeks after the federal warning.
F.D.A. Faces Upset Over Denials of New Drugs
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing
As AI and automation reshape drug…
As AI and automation reshape drug discovery, laboratories themselves are being forced to evolve. Gensler’s Ryley Poblete joins the podcast to explain how new technologies, the makeup of scientific teams and new ways of collaboration
The FDA has approved the first…
The FDA has approved the first true generic version of GSK's asthma inhaler Flovent, signing off on Glenmark's fluticasone propionate inhalation aerosol. For more than two years, Prasco Laboratories has sold an "authorized generic" version
After delivering solid sales…
After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S. generics
Galderma has doubled its peak…
Galderma has doubled its peak annual sales estimate for Nemluvio (nemolizumab) to more than $4 billion, following what CEO Flemming Ørnskov described as an “outstanding launch trajectory” for the Dupixent competitor in its first full
Leo Pharma has decided “It’s…
Leo Pharma has decided “It’s GO time” for the launch of its JAK inhibitor cream Anzupgo. Having built its growth plans on the recently approved medicine, the Danish drugmaker is running a direct-to-consumer campaign, including
Forma Life Sciences, which…
Forma Life Sciences, which inherited BioDuro’s California operations earlier this year, officially launched as a CDMO with a focus on oral solid dosage drugs this week.
Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds
In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.
Eli Lilly has officially launched…
Eli Lilly has officially launched Employer Connect, its direct-to-employer platform for its obesity medications, after teasing the rollout late last year.
Collegium Pharmaceutical has…
Collegium Pharmaceutical has tapped an appropriately glitzy star as the face of a new campaign spotlighting the bright side of life with attention-deficit/hyperactivity disorder.
BioDuro, headquartered in…
BioDuro, headquartered in California, has set up a new joint venture with Taiwan drug ingredients manufacturer, Cenra API Solutions. The new enterprise will see Cenra’s commercial-scale facility in Taipei folded into BioDuro’s production network.
The company has been pressing the…
The company has been pressing the FDA to hold a formal hearing on its proposed jet lag label expansion for Hetlioz since it was first snubbed way back in 2019.
The primary growth drivers in…
The primary growth drivers in Bayer’s pharma sector—Nubeqa and Kerendia—are performing even better than the company anticipated and their momentum is expected to continue in 2026. But that won’t lead to growth of Bayer’s pharma
Not long after Novo Nordisk…
Not long after Novo Nordisk received an untitled letter from the FDA disputing certain elements of the first TV spot for its Wegovy pill, another of the Danish drugmaker’s GLP-1 ads is in the regulator’s
Traditional feasibility misses…
Traditional feasibility misses critical signals about patient reality. Patient journey intelligence reveals them, making truly patient-centric trials possible.
Moderna will pay $950 million…
Moderna will pay $950 million upfront—and no future royalties—to settle patent litigation over its mRNA-based vaccine Spikevax. The case was brought by Roivant subsidiary Genevant and infectious disease biotech Arbutus back in 2022.
Patient Advocate Foundation and…
Patient Advocate Foundation and PAN Foundation announce merger, creating a single destination for patients facing access and affordability challenges.
NoA Health has appointed Louisa…
NoA Health has appointed Louisa Lee as CEO, putting the former Novo Nordisk and Pfizer employee at the head of the creative agency’s push to take its business global.
Sanofi is betting $1.53 billion on…
Sanofi is betting $1.53 billion on a novel drug from Sino Biopharmaceutical, securing global rights to a first-in-class JAK/ROCK inhibitor that could play a double role in the French pharma’s hematology and immunology pipeline.